45 related articles for article (PubMed ID: 11843628)
21. Identification of Mxr1p-binding sites in the promoters of genes encoding dihydroxyacetone synthase and peroxin 8 of the methylotrophic yeast Pichia pastoris.
Kranthi BV; Kumar HR; Rangarajan PN
Yeast; 2010 Sep; 27(9):705-11. PubMed ID: 20198661
[TBL] [Abstract][Full Text] [Related]
22. Clusters of regulatory signals for RNA polymerase II transcription associated with Alu family repeats and CpG islands in human promoters.
Oei SL; Babich VS; Kazakov VI; Usmanova NM; Kropotov AV; Tomilin NV
Genomics; 2004 May; 83(5):873-82. PubMed ID: 15081116
[TBL] [Abstract][Full Text] [Related]
23. High-resolution transcription assay for probing drug-DNA interactions at individual drug sites.
Phillips DR; Cutts SM; Cullinane CM; Crothers DM
Methods Enzymol; 2001; 340():466-85. PubMed ID: 11494864
[No Abstract] [Full Text] [Related]
24. Recognising promoter sequences using an artificial immune system.
Cooke DE; Hunt JE
Proc Int Conf Intell Syst Mol Biol; 1995; 3():89-97. PubMed ID: 7584471
[TBL] [Abstract][Full Text] [Related]
25. Mesoscopic model for free-energy-landscape analysis of DNA sequences.
Tapia-Rojo R; Prada-Gracia D; Mazo JJ; Falo F
Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Aug; 86(2 Pt 1):021908. PubMed ID: 23005786
[TBL] [Abstract][Full Text] [Related]
26. Serially balanced sequences in bioassay.
FINNEY DJ; OUTHWAITE AD
Proc R Soc Lond B Biol Sci; 1956 Aug; 145(921):493-507. PubMed ID: 13359400
[No Abstract] [Full Text] [Related]
27. Thermodynamic characterization of the multivalent binding of chartreusin to DNA.
Barceló F; Capó D; Portugal J
Nucleic Acids Res; 2002 Oct; 30(20):4567-73. PubMed ID: 12384604
[TBL] [Abstract][Full Text] [Related]
28. Site-specific analysis of drug interactions and damage in DNA using sequencing techniques.
Wilkins RJ
Anal Biochem; 1985 Jun; 147(2):267-79. PubMed ID: 3893215
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of DNA sequences specifically recognized by drugs in human promoters.
Mansilla S; Portugal J
J Biomol Struct Dyn; 2002 Feb; 19(4):669-79. PubMed ID: 11843628
[TBL] [Abstract][Full Text] [Related]
30. Selective binding of small molecules to DNA: application and perspectives.
Wang B; Tan J; Zhu L
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):1-4. PubMed ID: 20447811
[TBL] [Abstract][Full Text] [Related]
31. Systematic search for the Cra-binding promoters using genomic SELEX system.
Shimada T; Fujita N; Maeda M; Ishihama A
Genes Cells; 2005 Sep; 10(9):907-18. PubMed ID: 16115199
[TBL] [Abstract][Full Text] [Related]
32. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
33. Chimpanzee, orangutan, mouse, and human cell cycle promoters exempt CCAAT boxes and CHR elements from interspecies differences.
Müller GA; Heissig F; Engeland K
Mol Biol Evol; 2007 Mar; 24(3):814-26. PubMed ID: 17205977
[TBL] [Abstract][Full Text] [Related]
34. UV light as a footprinting agent: modulation of UV-induced DNA damage by transcription factors bound at the promoters of three human genes.
Tornaletti S; Pfeifer GP
J Mol Biol; 1995 Jun; 249(4):714-28. PubMed ID: 7602584
[TBL] [Abstract][Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
